Back to ENL
Elsevier Announces Two Tetrahedron Symposia for 2012

AMSTERDAM, January 10, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced it will organize an extra Tetrahedron Symposium in 2012. In an effort to bring the world class speakers in bioorganic and organic medicinal chemistry closer to researchers, Tetrahedron's annual symposium will this year be held in two locations, one in Europe and one in Asia.

Professor Chi-Huey Wong, Academia Sinica, Taiwan and Chairman of the 13th Tetrahedron Symposium Asia, said of the planned symposium in Taipei, "I am excited by this novel concept of having the world-class Tetrahedron Symposium hosted in two venues in 2012. This will enable many more scientists to participate than is possible for more traditional meetings. I am also very pleased that so many distinguished colleagues have enthusiastically agreed to participate."

Professor Stephen Neidle, UCL School of Pharmacy, London and Chairman of the 13th Tetrahedron Symposium Europe, said of the planned symposium in Amsterdam, "These are exciting times for the chemistry and life sciences field and I am delighted that the planned symposium will reflect this, with an outstanding group of speakers. The symposium will also be an opportunity for many scientists to present and discuss their latest work in the stimulating environment of the Tetrahedron Symposium."

Diddel Francissen, Executive Publisher of Elsevier's Tetrahedron journals added, "Nothing compares to actually physically attending a symposium. With top international speakers such as Michael Famulok (Europe), Shigeki Sasaki (Asia), Clifton Barry (USA), the symposium can be held anywhere in the world. We are very pleased to have created more opportunities for researchers across the word to attend the event, present their work and interact with internationally renowned scientists. This symposium duplication is a first for Elsevier, and if successful, can pave the way for future duplications of symposia and conferences."

The 13th Tetrahedron Symposium Europe will take place in Amsterdam, The Netherlands 26-29 June 2012; the 13th Tetrahedron Symposium Asia will take place in Taipei, Taiwan 27-30 November 2012.

For more information please visit: http://www.tetrahedron-symposium.elsevier.com or http://www.tetrahedronsymposiumasia.com

About Elsevier's Tetrahedron journals

Elsevier's Tetrahedron cluster of journals consists of: Tetrahedron, Tetrahedron Letters, Tetrahedron Assymetry, Bioorganic and Medicinal Chemistry and Bioorganic and Medicinal Chemistry Letters. All these journals provide an international forum for the publication of research in all areas of (bio)organic and medicinal chemistry.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet [http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus [http://www.scopus.nl ], Reaxys [http://www.reaxys.com ], MD Consult [http://www.mdconsult.com ] and Nursing Consult [http://www.nursingconsult.com ], which enhance the productivity of science and health professionals, and the SciVal suite [http://www.scival.com ] and MEDai's Pinpoint Review [http://www.medai.com ], which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ] employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc [http://www.reedelsevier.com ], a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV; the combined market capitalization of the two parent companies is approximately GBP12bn/EUR13bn. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        
        Media contact
        Darren Sugrue
        Elsevier
        +31-20-485-3506
        d.sugrue@elsevier.com

SOURCE Elsevier

Copyright (2014) PR Newswire. All Rights Reserved.
Back to ENL
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki